Stock 6185 CANSINO BIOLOGICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CanSino Biologics Inc.

Equities

6185

CNE100003F01

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-16 am EDT 		5-day change 1st Jan Change
17.18 HKD -1.26% Intraday chart for CanSino Biologics Inc. -10.24% -27.05%
Mar. 21 Cansino Biologics Begins Phase III Clinical Trials for Tetanus Drug MT
Mar. 20 Cansino Biologics Inc. Announces Initiation of Phase III Clinical Trial and Completion of First Trial Patient Case for Absorbed Tetanus Vaccine CI

Evolution of the average Target Price on CanSino Biologics Inc.

Price target over the last 5 years

History of analyst recommendation changes

fe22961a02a6de58cd.0enoxsBj_mJsQc2WEamJoAJq4FSP4o_agspHuyw4deI.gNCjifcuxxFVNr_HRv_R1kMk1CbjqMju6IEpzVhoOYmBtq-38S2_Ox4jhA~5d33919fa247513b39cc9e3944b2ed4d

Analyst Recommendations on CanSino Biologics Inc.

Shares in Chinese Pharma Companies Decline Amid Drop in Vaccination Rates MT
Hong Kong Stocks Fall after Fed's Fourth Jumbo Rate Hike; Cansino Slumps 35% MT
UBS Adjusts CanSino Biologics' Price Target to HK$88 From HK$200, Keeps at Buy MT
UBS Adjusts CanSino Biologics’ Price Target to HK$200 From HK$202, Keeps at Buy MT
China stocks fall as virus worries, Fed rate hike bets weigh; Hong Kong up RE
Market Chatter: CanSino's COVID-19 Vaccine Achieves 65.7% Efficacy Rate for Symptomatic Cases MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.09 CNY
Average target price
24.32 CNY
Spread / Average Target
+51.20%
High Price Target
38.36 CNY
Spread / Highest target
+138.45%
Low Price Target
17.09 CNY
Spread / Lowest Target
+6.25%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CanSino Biologics Inc.

UBS

Ratings for CanSino Biologics Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 6185 Stock
  4. Consensus CanSino Biologics Inc.